ba0004p193 | (1) | ICCBH2015
den Hoed MAH
, SMF Pluijm
, de Groot-Kruseman HA
, Fiocco M
, Hoogerbrugge P
, JA Leeuw
, MCA Bruin
, van der Sluis IM
, Bresters D
, MH Lequin
, JC Roos
, AJP Veerman
, Pieters R
, van den Heuvel-Eibrink MM
Objectives: Osteonecrosis (ON) and decline of bone mineral density (BMD) are serious side effects during and after treatment of childhood acute lymphoblastic leukemia (ALL). It is unknown whether ON and low BMD co-occur in the same patients, and whether these two osteogenic side-effects can mutually influence each others development.Methods: BMD and the incidence of symptomatic ON were prospectively assessed in a national cohort of 466 patients wit...